Price Alert

Pacira BioSciences Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

24.75

-0.24 (-0.96%)

At close: Aug 15, 2025, 3:59 PM

24.78

0.12%

After-hours: Aug 15, 2025, 04:54 PM EDT

Pacira BioSciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	705.85M	702.77M	700.97M	694.96M	690.31M	681.75M	674.98M	665.69M	669.23M	669.17M	666.82M	654.06M	614.32M	580.5M	541.53M	510.89M	500.65M	440.56M
Cost of Revenue	153.92M	171.64M	199.07M	221.2M	222.09M	211.71M	198.99M	198.89M	209.82M	212.24M	199.29M	176.39M	160.36M	144.98M	140.25M	136.55M	131.89M	118.94M
Gross Profit	551.93M	531.13M	501.89M	473.76M	468.22M	470.05M	475.99M	466.8M	459.41M	456.93M	467.53M	477.68M	453.96M	435.52M	401.28M	374.34M	368.76M	321.62M
Operating Income	-104.33M	-81.86M	-68.73M	-59.47M	97.78M	106.68M	103.71M	86.85M	80.64M	52.67M	57.92M	45.02M	64.95M	87.88M	89.92M	104.5M	90.68M	48.69M
Interest Income	22.94M	22.68M	19.69M	17.56M	14.84M	12.21M	11.44M	10.8M	9.27M	7.41M	4.54M	1.84M	779K	751K	895K	1.51M	2.36M	3.46M
Pretax Income	-106.55M	-68.04M	-63.11M	-54.91M	100.55M	101.81M	61.7M	9.91M	-4.62M	-20.47M	13.3M	25.17M	47.34M	50.98M	56.41M	75.3M	57.22M	24.26M
Net Income	-127.46M	-103.73M	-99.56M	-90.73M	63.59M	70.47M	41.95M	6.98M	-4.57M	-10.46M	15.91M	20.88M	39.23M	38.44M	41.98M	61.62M	174.08M	147.73M
Selling & General & Admin	329.3M	308.85M	294.1M	280.29M	273.9M	270.62M	269.44M	267.61M	260.95M	261.1M	254.52M	241.75M	229.27M	215.08M	199.34M	200.97M	204.73M	197.26M
Research & Development	96.54M	88.68M	81.58M	77.14M	78.87M	77.36M	76.26M	74.3M	72.87M	80.33M	84.8M	82.81M	74.98M	61.27M	55.54M	55.36M	58.43M	59.48M
Other Expenses	230.42M	215.42M	194.75M	176.12M	-105K	-335K	14.15M	27.95M	42.7M	57.29M	57.29M	42.9M	28.53M	11.81M	-2.66M	-2.32M	434K	6.8M
Operating Expenses	656.26M	612.99M	570.63M	533.23M	367.09M	376.62M	388.66M	399.2M	391.11M	398.72M	396.6M	376.13M	343.47M	303.21M	269.39M	264.2M	271.03M	264.6M
Interest Expense	17.8M	17.83M	16.57M	15.28M	14.05M	14.03M	20.31M	27.96M	34.35M	39.32M	39.98M	39.36M	36.84M	35.02M	31.75M	28.39M	28.19M	26.62M
Selling & Marketing Expenses	200.07M	188.15M	172.01M	157.41M	152.48M	150.9M	153.04M	153.3M	148.74M	148.13M	145M	138.36M	130.96M	122.36M	111.02M	113.86M	120.78M	117.87M
Cost & Expenses	810.18M	784.63M	769.7M	754.43M	589.18M	588.33M	587.65M	598.09M	600.93M	610.96M	595.9M	552.51M	503.83M	448.19M	409.65M	400.75M	402.92M	383.55M
Income Tax Expense	20.91M	35.69M	36.45M	35.82M	36.95M	31.34M	19.75M	2.93M	-51K	-10.01M	-2.61M	4.29M	8.1M	12.54M	14.43M	13.67M	-116.87M	-123.48M
Shares Outstanding (Basic)	45.46M	46.27M	46.17M	46.13M	46.17M	46.5M	46.44M	46.42M	46.09M	45.95M	45.88M	45.83M	49.87M	44.87M	44.59M	44.48M	44.15M	43.83M
Shares Outstanding (Diluted)	45.46M	46.53M	49.04M	46.13M	50.54M	52.19M	52.06M	52.07M	52.05M	45.95M	45.88M	45.83M	52.48M	46.44M	44.59M	45.46M	45.59M	45.97M
EPS (Basic)	-2.77	-2.25	-2.16	-1.97	1.37	1.52	0.90	0.14	-0.11	-0.27	0.31	0.41	0.83	0.86	0.95	1.40	4.03	3.43
EPS (Diluted)	-2.78	-2.28	-2.19	-2.05	1.29	1.39	0.77	0.07	-0.18	-0.29	0.29	0.39	0.80	0.84	0.92	1.36	3.91	3.32
EBITDA	-455K	20.14M	21.91M	22.92M	177.18M	169.66M	137M	107.92M	110.39M	102.11M	141.16M	178.72M	174.07M	177.57M	161.97M	131.64M	117.66M	83.23M
EBIT	-91.29M	-53.5M	-49.67M	-42.6M	111.78M	113.11M	79.95M	35.05M	26.69M	15.63M	48.88M	60.8M	81.34M	84.04M	86.73M	102.39M	83.48M	48.51M
Depreciation & Amortization	89.99M	81.53M	78.78M	76.03M	74.21M	74.4M	75.57M	87.49M	89.26M	91.07M	91.5M	74.17M	59.73M	43.74M	28.55M	17.45M	13.65M	10.75M